Sunday, August 31, 2014 10:08:04 PM
claiming many layers of protection sounds nice...but its just words...could be only one may have an issue and they may decide they have no case...
"would be infringer"...lol...what is that?...someone who accomplishes what kblb has failed to do?...someone who does it differently but will be sued anyway?...
what you are failing to realize is that kblb's patent doesnt cover EVERYTHING...it cant...it didnt cover everything that had not been thought of either...this is cutting edge biotech...those patents are sitting on the shelf getting older and less relevant by the day while that cutting edge biotech is moving forward everyday...how much longer are those patents even going to matter much?...
sial, sgmo?....its all about the money for them...and kblb aint making any for them...they will go where the money is...at this point, i doubt they will too overly concerned with kblb...
kim made money for the companies he worked for suing others...those companies had the money and paid kim to do it...and i doubt he won them all...
but can kim do it all on his own dime and time?...or rather kblb shareholders money?...while running the company as well?...supposedly he doesnt even have the time to keep shareholders informed as it is...
its all well and good to talk lawsuits , infringement and partners...its quite another to do it yourself or get someone else to want to spend their time and money to do it... particularly if they are better off with them than you...
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM